Description
Class IIa Medical Device (Directive 93/42/EEC).
Complete solution for the treatment of upper and lower respiratory tracts, ideal for the whole family. Thanks to the two different aerosol ampoules provided, Nebula allows the drug to be deposited directly in the target organ (topical therapy).
Rinowash is a terminal for washing and treating the upper airways, producing particles with a diameter of 18 mcm that deposit in the nasal cavity up to the nasopharynx for the treatment of rhinitis, rhinosinusitis, and upper respiratory tract infections.
Nebula Spacer is a nebulizing ampoule with a volumetric buccal mask for the lower airways, ensuring bronchial deposition of the nebulized drug. It produces particles with a size of 1 to 5 mcm, which reach even the extreme parts such as pulmonary and bronchial alveoli.
Pediatric mask for children under 5 for the treatment of the lower airways.
Complete therapy for the upper and lower respiratory tracts. Professional performance ensuring safe and effective therapy. Low dispersion of the drug into the environment. Reduced therapy times. Durable and long-lasting materials.
Technical specifications
- Rinowash: MMAD 18 mcm (*)
- Nebula Spacer: MMAD 1.9 mcm (*)
Minimum nebulization: 0.3 ml/min
- Device
Continuous operation
Maximum air pressure: 2.7 bar
Maximum air flow: 12 l/min
Noise level at 1 m: 57 dBA (according to UNI EN 13544-1)
Base unit dimensions: 230x180x185 mm
Base unit weight: 3 kg
(*) The values indicated refer to the use of physiological saline solution (0.9% NaCl): they may vary depending on the medicine used. The indicated values do not apply to medicines delivered in suspension or with high viscosity. In this case, information should be requested from the drug manufacturer. Measured with API Aerosizer MACH2.

Format
1 piece.

Code. 401123